Suchen
Core Laboratories Inc
CLBZur Watchlist hinzufügen
11.460USD
-0.105-0.91%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
528.25MMarktkapitalisierung
18.33KGV TTM
mehr Informationen über Core Laboratories Inc Unternehmen
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.
Core Laboratories Inc Informationen
BörsenkürzelCLB
Name des UnternehmensCore Laboratories Inc
IPO-datumOct 22, 2018
CEOBruno (Lawrence V)
Anzahl der mitarbeiter3500
WertpapierartOrdinary Share
GeschäftsjahresendeOct 22
Addresse6316 Windfern Road
StadtHOUSTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl77040
Telefon17133282673
Websitehttps://www.corelab.com/
BörsenkürzelCLB
IPO-datumOct 22, 2018
CEOBruno (Lawrence V)
Führungskräfte von Core Laboratories Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Martha Z. Carnes, CPA
Ms. Martha Z. Carnes, CPA
Lead Independent Director
Lead Independent Director
54.40K
+14.83%
Mr. Kwaku Temeng
Mr. Kwaku Temeng
Independent Director
Independent Director
33.60K
+24.02%
Ms. Gwendolyn Y. Gresham
Ms. Gwendolyn Y. Gresham
Senior Vice President - Corporate Development and Investor Relations
Senior Vice President - Corporate Development and Investor Relations
33.23K
--
Mr. Curtis V. (Curt) Anastasio
Mr. Curtis V. (Curt) Anastasio
Independent Director
Independent Director
23.80K
+33.90%
Mr. Lawrence V. Bruno
Mr. Lawrence V. Bruno
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Christopher S. Hill
Mr. Christopher S. Hill
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Mr. Mark D. Tattoli
Mr. Mark D. Tattoli
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Ms. Katherine A. Murray
Ms. Katherine A. Murray
Independent Director
Independent Director
--
--
Mr. Harvey Klingensmith
Mr. Harvey Klingensmith
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Martha Z. Carnes, CPA
Ms. Martha Z. Carnes, CPA
Lead Independent Director
Lead Independent Director
54.40K
+14.83%
Mr. Kwaku Temeng
Mr. Kwaku Temeng
Independent Director
Independent Director
33.60K
+24.02%
Ms. Gwendolyn Y. Gresham
Ms. Gwendolyn Y. Gresham
Senior Vice President - Corporate Development and Investor Relations
Senior Vice President - Corporate Development and Investor Relations
33.23K
--
Mr. Curtis V. (Curt) Anastasio
Mr. Curtis V. (Curt) Anastasio
Independent Director
Independent Director
23.80K
+33.90%
Mr. Lawrence V. Bruno
Mr. Lawrence V. Bruno
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Christopher S. Hill
Mr. Christopher S. Hill
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Core Laboratories Inc?
Die fünf größten Anteilseigner von Core Laboratories Inc sind: Ms. Martha Z. Carnes, CPA
Wie viele Institutionen halten Anteile an Core Laboratories Inc (CLB)?
Mit Stand vom 2026Q1 halten 434 Institutionen Anteile an Core Laboratories Inc, mit einem Gesamtmarktwert von etwa 51.56M, was 111.85% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -5043400.00 gestiegen.
Was ist die größte Einnahmequelle von Core Laboratories Inc?
Am 2026Q1 erzielte das Geschäft mit Service für Core Laboratories Inc den höchsten Umsatz in Höhe von 399.42M, was 75.86% des Gesamtumsatzes entspricht.